Home » Topics » Regulatory

Regulatory
RSS

FDA approves new combination therapy product for HCV

June 4, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Actiq trial results published; NDA amendment filed

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

FDA approves test to identify risk of preterm labor

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...